Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Brodalumab in Plaque Psoriasis
jRCT2080222010Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brodalumab in plaque psoriasis, sponsored by Kyowa Kirin.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2080222010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222010.